Literature DB >> 3012073

Baclofen suppresses hippocampal epileptiform activity at low concentrations without suppressing synaptic transmission.

H S Swartzwelder, A C Bragdon, C P Sutch, B Ault, W A Wilson.   

Abstract

Baclofen is used clinically to treat spasticity, but has received little attention as a potential antiepileptic agent. To explore the antiepileptic potential of baclofen further, we tested its effect on stimulus train-induced bursting, an in vitro model of hippocampal epileptiform activity. In hippocampal slices prepared from male rats, extracellular field potentials were recorded in stratum pyramidale of CA3, and electrical stimuli were delivered to s. radiatum of CA3. After stable responses to single stimuli were established, stimulus trains were delivered every 5 min until stable triggered and spontaneous population bursting were elicited. (+/-)-Baclofen was bath-applied to the slices at varying concentrations to study its ability to suppress synaptic transmission and epileptiform activity. EC50 values for suppression of orthodromic population spike amplitude, of triggered burst duration and of spontaneous burst frequency were 2300, 355 and 26.9 nM, respectively; all statistically significantly different. These findings suggest that baclofen suppresses epileptiform electrical activity in the hippocampus at concentrations well below those which suppress normal synaptic transmission, and support renewed consideration of baclofen as an antiepileptic agent.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3012073

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  5 in total

1.  Baclofen disrupts passive avoidance retention in rats.

Authors:  H S Swartzwelder; H A Tilson; R L McLamb; W A Wilson
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

2.  Pore mutation in a G-protein-gated inwardly rectifying K+ channel subunit causes loss of K+-dependent inhibition in weaver hippocampus.

Authors:  W Jarolimek; J Bäurle; U Misgeld
Journal:  J Neurosci       Date:  1998-06-01       Impact factor: 6.167

3.  Paired-pulse depression of the N-methyl-D-aspartate receptor-mediated synaptic potentials in the amygdala.

Authors:  C C Huang; P W Gean
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

4.  Potential interactions between GABAb and cholinergic systems: baclofen augments scopolamine-induced performance deficits in the eight-arm radial maze.

Authors:  E S Sidel; H A Tilson; R L McLamb; W A Wilson; H S Swartzwelder
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

5.  Region-specific differences and areal interactions underlying transitions in epileptiform activity.

Authors:  Neela K Codadu; R Ryley Parrish; Andrew J Trevelyan
Journal:  J Physiol       Date:  2019-02-13       Impact factor: 5.182

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.